Patents by Inventor Keisuke JINBO

Keisuke JINBO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10869876
    Abstract: The present invention provides a rocuronium preparation with an excellent stability. The rocuronium preparation contains rocuronium and a buffer solution and having an adjusted pH of 3.5 or less (for example, 2.5 to 3.5). The buffer solution may be a citric acid-sodium hydroxide buffer solution, a tartaric acid-sodium hydroxide buffer solution, a potassium hydrogen phthalate-hydrochloric acid buffer solution, a glycine-hydrochloric acid buffer solution, or the like. Such a rocuronium preparation has, for example, after 6-month storage at 40° C., a generation rate of rocuronium-related substance C of 5% or less.
    Type: Grant
    Filed: June 26, 2014
    Date of Patent: December 22, 2020
    Assignee: MARUISHI PHARMACEUTICAL CO., LTD.
    Inventors: Yutaka Itsuji, Hironori Nagahara, Keisuke Jinbo
  • Patent number: 10821119
    Abstract: Provided is a rocuronium preparation designed to reduce vascular pain to be induced. The rocuronium preparation contains rocuronium and a buffer solution, and has titratable acidity of 100 mEg or less. The buffer solution may be an acetate buffer solution, a citrate buffer solution, a formate buffer solution, a tartrate buffer solution, a phosphate buffer solution, a glycine-hydrochloric acid buffer solution, or a citric acid-phosphate buffer solution.
    Type: Grant
    Filed: June 23, 2014
    Date of Patent: November 3, 2020
    Assignee: MARUISHI PHARMACEUTICAL CO., LTD.
    Inventors: Keisuke Jinbo, Yutaka Itsuji
  • Publication number: 20170128463
    Abstract: The present invention provides a rocuronium preparation with an excellent stability. The rocuronium preparation contains rocuronium and a buffer solution and having an adjusted pH of 3.5 or less (for example, 2.5 to 3.5). The buffer solution may be a citric acid-sodium hydroxide buffer solution, a tartaric acid-sodium hydroxide buffer solution, a potassium hydrogen phthalate-hydrochloric acid buffer solution, a glycine-hydrochloric acid buffer solution, or the like. Such a rocuronium preparation has, for example, after 6-month storage at 40° C., a generation rate of rocuronium-related substance C of 5% or less.
    Type: Application
    Filed: June 26, 2014
    Publication date: May 11, 2017
    Applicant: MARUISHI PHARMACEUTICAL CO., LTD.
    Inventors: Yutaka ITSUJI, Hironori NAGAHARA, Keisuke JINBO
  • Publication number: 20160143919
    Abstract: Provided is a rocuronium preparation designed to reduce vascular pain to be induced. The rocuronium preparation contains rocuronium and a buffer solution, and has titratable acidity of 100 mEg or less. The buffer solution may be an acetate buffer solution, a citrate buffer solution, a formate buffer solution, a tartrate buffer solution, a phosphate buffer solution, a glycine-hydrochloric acid buffer solution, or a citric acid-phosphate buffer solution.
    Type: Application
    Filed: June 23, 2014
    Publication date: May 26, 2016
    Applicant: MARUISHI PHARMACEUTICAL CO., LTD.
    Inventors: Keisuke JINBO, Yutaka ITSUJI